These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18160963)

  • 21. Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients.
    Beran J
    Expert Opin Biol Ther; 2008 Feb; 8(2):235-47. PubMed ID: 18194079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
    Li H; Li R; Liao S; Yang J; Zeng X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
    Wu Q; Zhuang GH; Wang XL; Wang LR; Li N; Zhang M
    Vaccine; 2011 Mar; 29(12):2302-7. PubMed ID: 21277403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04.
    Boland G; Beran J; Lievens M; Sasadeusz J; Dentico P; Nothdurft H; Zuckerman JN; Genton B; Steffen R; Loutan L; Van Hattum J; Stoffel M
    Vaccine; 2004 Dec; 23(3):316-20. PubMed ID: 15530674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
    Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
    Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
    Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L
    Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety of an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials.
    Tielemans CL; Vlasak J; Kosa D; Billiouw JM; Verpooten GA; Mezei I; Ryba M; Peeters PC; Mat O; Jadoul MY; Polakovic V; Dhaene M; Treille S; Kuriyakose SO; Leyssen M; Houard SA; Surquin M
    Vaccine; 2011 Feb; 29(6):1159-66. PubMed ID: 21167859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel perspectives on the hepatitis B virus vaccine in the chronic kidney disease population.
    Fabrizi F; Martin P; Messa P
    Int J Artif Organs; 2015 Dec; 38(12):625-31. PubMed ID: 26821784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis.
    Onuigbo MA; Nesbit A; Weisenbeck J; Hurlburt J
    Ren Fail; 2010 May; 32(4):531-2. PubMed ID: 20446799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term evaluation of immune response to hepatitis B vaccine in 136 patients undergoing hemodialysis].
    Pin M; Compte MT; Angelet P; Gállego C; Gutiérrez C; Martinez Vea A
    Nefrologia; 2009; 29(5):415-20. PubMed ID: 19820753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
    Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
    Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
    Alavian SM; Tabatabaei SV
    Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 2-dose regimen of a recombinant hepatitis B vaccine with the immune stimulant AS04 compared with the standard 3-dose regimen of Engerix-B in healthy young adults.
    Levie K; Gjorup I; Skinhøj P; Stoffel M
    Scand J Infect Dis; 2002; 34(8):610-4. PubMed ID: 12238579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
    Chaves SS; Daniels D; Cooper BW; Malo-Schlegel S; Macarthur S; Robbins KC; Kobetitsch JF; McDaniel A; D'Avella JF; Alter MJ
    Vaccine; 2011 Dec; 29(52):9618-23. PubMed ID: 22044739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immune response to hepatitis B vaccine and duration of protection in a dialysis unit].
    Magnani G; Calzetti C; Campari M; Lehndorff H; Pizzaferri P; Rossi E
    Acta Biomed Ateneo Parmense; 1987; 58(1-2):41-7. PubMed ID: 2960120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prospective study of HBV circulation and long-term evaluation of anti-hepatitis-B vaccination in patients undergoing hemodialysis].
    Portelli V; Cesare S; Galanti B; Genovese G; Pappalardo MS; Colimberti D
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):469-73. PubMed ID: 2152307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand.
    Poovorawan Y; Chongsrisawat V; Theamboonlers A; Bock HL; Leyssen M; Jacquet JM
    Vaccine; 2010 Jan; 28(3):730-6. PubMed ID: 19892043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.